Return to homepagePandemic Pact

Role of SARS-CoV2-Infected Lung Cells and Humoral Response in the Evolution of COVID-19: From Pathophysiology to Drug Candidate Testing in Mucosal Cell Models]

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    N/A

  • Known Financial Commitments (USD)

    $173,923.2

  • Funder

    Other funders (France)

  • Principal Investigator

    Morgane BOMSEL

  • Research Location

    France

  • Lead Research Institution

    Institut Cochin à Paris

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Immunity

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

The MUCOLUNG project aims to study lung cells infected with Sars-CoV-2 as well as the immune response set up against the virus within the lung. The final objective is to better understand the elements that are involved in the occurrence of cytokine storms, the inappropriate inflammatory reactions involved in the most severe forms of the disease.